cannabis in Germany

cannabis in Germany
Name	Cannabis
Legality	Decriminalized for personal use, legal for medical use
Med use	Legal since 2017
Rec use	Limited legalization for social clubs enacted 2024

cannabis in Germany. The regulation and cultural position of cannabis in Germany has undergone significant transformation, evolving from strict prohibition to a more liberalized model in the 21st century. Landmark legislation passed by the Bundestag in 2024 established a framework for controlled recreational access, building upon earlier reforms for medical cannabis. This shift places Germany among the most progressive nations in Europe regarding cannabis policy, influencing debates within the European Union.

History

Cannabis was historically regulated under the Opium Law of 1929, which placed it under strict narcotics control. The post-war era saw enforcement guided by the Narcotics Act (Betäubungsmittelgesetz), aligning with the international prohibitionist consensus of the Single Convention on Narcotic Drugs. The modern reform movement gained momentum in the 1990s, with figures like Jürgen Trittin of Bündnis 90/Die Grünen advocating for change. A pivotal case occurred in 1994 when the Federal Constitutional Court ruled that minimal possession for personal use could avoid prosecution, leading to varied enforcement across Bundesländer like Berlin and Hamburg. The appointment of Karl Lauterbach as Federal Minister of Health in the Cabinet Scholz marked a decisive turn, culminating in the 2024 "Cannabis Act" passed by the traffic light coalition.

Legal status

The legal framework is defined by the 2024 Cannabis Act (CanG). Adults may possess up to 25 grams in public and cultivate up to three plants privately. Membership in non-commercial cannabis social clubs, licensed by authorities like the Federal Office for Agriculture and Food, allows for the collective cultivation and distribution of limited quantities. Medical use has been legal since 2017, with prescriptions covered by statutory health insurance under specific conditions. Driving under the influence remains strictly prohibited, regulated by the Road Traffic Act and enforced by the Federal Police. The law maintains a distance requirement from facilities like schools and kindergartens, and full commercial sales remain prohibited under European Union law.

Medical use

Medical cannabis was legalized in Germany by a vote in the Bundestag in March 2017. Patients can receive prescriptions for cannabis flowers or extracts for conditions such as chronic pain, multiple sclerosis, and chemotherapy-induced nausea, when standard therapies are inadequate. The Federal Institute for Drugs and Medical Devices oversees the cultivation and import of medical cannabis, with licensed producers including companies like Aurora Cannabis and Canopy Growth Corporation. Reimbursement by public health insurance requires prior authorization, a process often involving the Gemeinsamer Bundesausschuss. Major distributing pharmacies include DocMorris and Shop Apotheke.

Cultivation and production

Domestic cultivation for the medical market is strictly licensed by the Federal Institute for Drugs and Medical Devices, with production occurring in secure facilities. The 2024 law permits personal home cultivation and establishes the model for member-based cannabis social clubs, which can collectively grow cannabis for distribution. Large-scale commercial production for recreational retail remains illegal. Imported medical cannabis primarily comes from countries like Canada, Portugal, and the Netherlands. The Federal Ministry of Food and Agriculture is involved in regulatory aspects for non-medical cultivation clubs.

Public opinion and culture

Public support for legalization grew steadily, influenced by advocacy groups like the German Hemp Association and events such as the Hanfparade in Berlin. Cannabis culture is visible in cities like Cologne and Frankfurt, and has been referenced in German media, including films by directors like Fatih Akin. The annual Cannabis Fair in Hanover showcases products and advocacy. Opposition to liberalization has been voiced by organizations including the German Police Union and the Christian Democratic Union of Germany, particularly under figures like Friedrich Merz.

Economic impact

The regulated medical market has generated significant revenue for licensed producers and distributors such as Cansativa GmbH. The establishment of a recreational cultivation club system is projected to create jobs and shift economic activity from the illicit market. The law is expected to reduce costs for the judiciary and law enforcement associated with prosecution. Tax implications and the potential for future regulated commercial sales are subjects of analysis by institutes like the German Institute for Economic Research. The market also supports ancillary businesses in sectors like security technology and agricultural equipment.

Category:Cannabis by country Category:Drugs in Germany Category:German law